Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical in… Read more
Unichem Laboratories Limited (UNICHEMLAB) - Total Liabilities
Latest total liabilities as of September 2025: ₹11.21 Billion INR
Based on the latest financial reports, Unichem Laboratories Limited (UNICHEMLAB) has total liabilities worth ₹11.21 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Unichem Laboratories Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Unichem Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Unichem Laboratories Limited Competitors by Total Liabilities
The table below lists competitors of Unichem Laboratories Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jeffersonville Bancorp
OTCQB:JFBC
|
USA | $576.67 Million |
|
SPML Infra Limited
NSE:SPMLINFRA
|
India | ₹12.23 Billion |
|
Vimta Labs Limited
NSE:VIMTALABS
|
India | ₹1.02 Billion |
|
Chaowei Power Holdings Limited
STU:EWC
|
Germany | €16.73 Billion |
|
Genasys Inc
NASDAQ:GNSS
|
USA | $65.84 Million |
|
Elanders AB Series B
LSE:0JBY
|
UK | Skr8.52 Billion |
|
MSP Steel & Power Limited
NSE:MSPL
|
India | ₹5.90 Billion |
|
DT Cloud Star Acquisition Corporation Units
NASDAQ:DTSQU
|
USA | $795.62K |
Liability Composition Analysis (2005–2025)
This chart breaks down Unichem Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.19 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Unichem Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Unichem Laboratories Limited (2005–2025)
The table below shows the annual total liabilities of Unichem Laboratories Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹11.19 Billion | +38.65% |
| 2024-03-31 | ₹8.07 Billion | +6.49% |
| 2023-03-31 | ₹7.58 Billion | +8.19% |
| 2022-03-31 | ₹7.00 Billion | +23.11% |
| 2021-03-31 | ₹5.69 Billion | -7.26% |
| 2020-03-31 | ₹6.13 Billion | +15.80% |
| 2019-03-31 | ₹5.30 Billion | +4.09% |
| 2018-03-31 | ₹5.09 Billion | +10.12% |
| 2017-03-31 | ₹4.62 Billion | +40.29% |
| 2016-03-31 | ₹3.29 Billion | +9.39% |
| 2015-03-31 | ₹3.01 Billion | -8.20% |
| 2014-03-31 | ₹3.28 Billion | -5.03% |
| 2013-03-31 | ₹3.45 Billion | +5.97% |
| 2012-03-31 | ₹3.26 Billion | +23.66% |
| 2011-03-31 | ₹2.64 Billion | +10.88% |
| 2010-03-31 | ₹2.38 Billion | +8.86% |
| 2009-03-31 | ₹2.18 Billion | +14.09% |
| 2008-03-31 | ₹1.91 Billion | -0.60% |
| 2007-03-31 | ₹1.93 Billion | +18.79% |
| 2006-03-31 | ₹1.62 Billion | -20.72% |
| 2005-03-31 | ₹2.04 Billion | -- |